Şerban R. Iorga

Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan

Daniel E. Fürst, Anthony A. Amato, Şerban R. Iorga et al. · Muscle & Nerve · 2012 · 185 citations

Medicine, Internal Medicine, Clinical Epidemiology +7

The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients

Mirko Sikirica, Şerban R. Iorga, Tim Bancroft et al. · BMC Health Services Research · 2014 · 108 citations · Full text

Medicine, Cardiology, Pharmacoeconomics +14

Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany

Winfried März, Franz‐Werner Dippel, Karlheinz Theobald et al. · Atherosclerosis · 2017 · 89 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Epidemiology of Systemic Sclerosis in a Large US Managed Care Population

Daniel E. Fürst, Ancilla W. Fernandes, Şerban R. Iorga et al. · The Journal of Rheumatology · 2012 · 55 citations

Medicine, Health Services Administration, Clinical Epidemiology +8

Annual Medical Costs and Healthcare Resource Use in Patients with Systemic Sclerosis in an Insured Population

Daniel E. Furst, Ancilla W. Fernandes, Şerban R. Iorga et al. · The Journal of Rheumatology · 2012 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17